Mode of Action of Antiretroviral Drugs
CCR5 antagonists prevent HIV from entering cells by blocking a membrane receptor
Fusion inhibitors prevent HIV from entering cells by binding a viral protein needed for entry
Integrase inhibitors impair the function of HIV's integrase enzyme
NRTIs bind active sites on HIV's reverse transcriptase enzyme, blocking DNA production
PIs inhibit HIV's protease enzyme, which cleaves HIV's gene products